|
| 37688579 | Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival. | J Natl Cancer Inst | 2024 |
| 37688579 | Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival. | J Natl Cancer Inst | 2024 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 35604410 | Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. | Neuro Oncol | 2023 |
| 37081608 | Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma. | Cancer | 2023 |
| 36747619 | Germline pathogenic variants in 786 neuroblastoma patients. | medRxiv | 2023 |
| 36541551 | Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants. | Neuro Oncol | 2023 |
| 37492101 | OpenPBTA: The Open Pediatric Brain Tumor Atlas. | Cell Genom | 2023 |
| 37492101 | OpenPBTA: The Open Pediatric Brain Tumor Atlas. | Cell Genom | 2023 |
| 35604410 | Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. | Neuro Oncol | 2023 |
| 37081608 | Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma. | Cancer | 2023 |
| 36747619 | Germline pathogenic variants in 786 neuroblastoma patients. | medRxiv | 2023 |
| 36541551 | Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants. | Neuro Oncol | 2023 |
| 34992263 | Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. | Nat Med | 2022 |
| 35973991 | Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. | Nat Commun | 2022 |
| 35836290 | Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma. | Acta Neuropathol Commun | 2022 |
| 34992263 | Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. | Nat Med | 2022 |
| 35836290 | Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma. | Acta Neuropathol Commun | 2022 |
| 35973991 | Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. | Nat Commun | 2022 |
| 33355208 | DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. | Cancer Discov | 2021 |
| 33355208 | DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. | Cancer Discov | 2021 |
| 31613963 | Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. | Neuro Oncol | 2020 |
| 31857431 | Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). | Clin Cancer Res | 2020 |
| 32015155 | Targeting ATRX Loss through Inhibition of the Cell-Cycle Checkpoint Mediator WEE1. | Cancer Res | 2020 |
| 32297094 | Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature. | J Neurooncol | 2020 |
| 31613963 | Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. | Neuro Oncol | 2020 |
| 32895736 | Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns. | Acta Neuropathol | 2020 |
| 32554798 | A germline <i>PALB2</i> pathogenic variant identified in a pediatric high-grade glioma. | Cold Spring Harb Mol Case Stud | 2020 |
| 32015155 | Targeting ATRX Loss through Inhibition of the Cell-Cycle Checkpoint Mediator WEE1. | Cancer Res | 2020 |
| 31857431 | Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). | Clin Cancer Res | 2020 |
| 32895736 | Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns. | Acta Neuropathol | 2020 |
| 32554798 | A germline <i>PALB2</i> pathogenic variant identified in a pediatric high-grade glioma. | Cold Spring Harb Mol Case Stud | 2020 |
| 32297094 | Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature. | J Neurooncol | 2020 |
| 30608896 | Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue. | J Clin Oncol | 2019 |
| 30608896 | Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue. | J Clin Oncol | 2019 |
| 30563935 | Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models. | Clin Cancer Res | 2019 |
| 31504801 | Immunotherapy for pediatric brain tumors: past and present. | Neuro Oncol | 2019 |
| 30895380 | Endoscopic third ventriculostomy prior to resection of posterior fossa tumors in children. | Childs Nerv Syst | 2019 |
| 31512931 | Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy. | Acta Oncol | 2019 |
| 31512931 | Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy. | Acta Oncol | 2019 |
| 31504801 | Immunotherapy for pediatric brain tumors: past and present. | Neuro Oncol | 2019 |
| 30895380 | Endoscopic third ventriculostomy prior to resection of posterior fossa tumors in children. | Childs Nerv Syst | 2019 |
| 30563935 | Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models. | Clin Cancer Res | 2019 |
| 27729458 | Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma. | Clin Cancer Res | 2017 |
| 28667701 | The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma. | J Cell Mol Med | 2017 |
| 29056344 | Comprehensive Analysis of Hypermutation in Human Cancer. | Cell | 2017 |
| 27729458 | Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma. | Clin Cancer Res | 2017 |
| 29056344 | Comprehensive Analysis of Hypermutation in Human Cancer. | Cell | 2017 |
| 28667701 | The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma. | J Cell Mol Med | 2017 |